Paltotx
1 known investors
Palto Therapeutics develops formulations for biological drugs, focusing on oligonucleotide therapeutics such as siRNAs and antisense oligonucleotides that deliver directly into diseased cells and activate in the cytoplasm. It works on proprietary delivery and formulation strategies aimed at addressing in vivo stability and targeted tissue/cell distribution for these next-generation drugs.
BiotechHealthtech
Investors · 1
Frequently asked questions
- What does Paltotx do?
- Palto Therapeutics develops formulations for biological drugs, focusing on oligonucleotide therapeutics such as siRNAs and antisense oligonucleotides that deliver directly into diseased cells and activate in the cytoplasm. It works on proprietary delivery and formulation strategies aimed at addressing in vivo stability and targeted tissue/cell distribution for these next-generation drugs.
- Who are Paltotx's investors?
- Paltotx's investors include Kickfund.